Chief Medical Officer · GILEAD SCIENCES, INC. (GILD)

Merdad Parsey

A named executive officer of GILEAD SCIENCES in every fiscal year CompBrief holds from FY2019 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$8,111,131

Salary $1,141,486Stock awards $4,206,347

FY2023: $8,386,847

3rd of 5 named executive officers at Gilead Sciences by FY2024 total.

5 named officers on file for GILEAD SCIENCES, FY2024

Merdad Parsey’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 18 equity grants, each cited to its filing
  • GILD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GILEAD SCIENCES’s whole pay program stands against its peers

  • GILEAD SCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GILD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 27, 2025 (DEF 14A).

Free

Get Merdad Parsey’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Merdad Parsey compensation by year

GILEAD SCIENCES Summary Compensation Table · all 6 fiscal years held
In US dollars, as GILEAD SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024
Salary$119,231$1,038,462$1,024,808$1,072,800$1,108,215$1,141,486
Bonus$1,000,000$1,000,000$0$0—$0
Stock awards$1,000,314$2,332,860$2,773,579$4,350,004$4,269,768$4,206,347
Option awards$1,000,008$1,000,033$1,062,502$1,612,496$1,324,984$1,325,004
Non-equity incentive$0$1,794,000$1,640,790$1,986,552$1,657,632$1,410,810
Pension and deferred compensation$0$0$0$0—$0
All other$0$15,000$15,000$15,362$26,248$27,484
Total$3,119,553$7,180,355$6,516,679$9,037,214$8,386,847$8,111,131

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GILEAD SCIENCES, INC. DEF 14A filed March 27, 2025, accession 0001308179-25-000252, and prior-year filings.

How this page was built: the GILEAD SCIENCES, INC. filed document, accession 0001308179-25-000252. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2025.

$3.1M
$7.2M
$6.5M
$9.0M
$8.4M
$8.1M
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU54,340$5,019,386—
PSU18,810$1,737,480—
RSU18,560$1,714,387—
RSU17,640$1,629,407—
RSU16,372$1,512,261—
PSU15,120$1,396,634—
RSU12,654$1,168,869—
RSU10,373$958,200—
RSU9,800$905,238—
RSU9,374$865,876—
RSU8,700$803,619—
RSU7,575$699,684—

Per the Outstanding Equity Awards at Fiscal Year-End table in GILEAD SCIENCES, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 17 award rows shown.

GILEAD SCIENCES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Daniel O'DayChairman and Chief Executive Officer$23,689,392
Johanna MercierChief Commercial Officer$8,609,065
Merdad Parsey · this pageChief Medical Officer$8,111,131
Andrew DickinsonChief Financial Officer$8,109,758
Deborah TelmanExecutive Vice President, Corporate Affairs and General Counsel$6,071,879

The full GILEAD SCIENCES compensation record

free company brief

This page is one person within GILEAD SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GILEAD SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GILEAD SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Merdad Parsey's compensation dossier · One-time report. No refunds.